CANNACTIVA

💥 PRE-BLACK FRIDAY: UP TO -40%! 🚀

⭐ +15,000 reviews — 4.8/5

🔥 LIMITED OFFERS · FILL YOUR CART! 🛒

🚀 Free shipping in 48-72 h from €60 🔥

💥 PRE-BLACK FRIDAY: UP TO -40%! 🚀

CBD FlowerCBD HashCBD oilCBD physiotherapyCBD skincareAccessoriesCBD bundlesArtClothingCannabis booksBlog
Cannactiva CBD footer

CBD and hemp derivatives made with love

CBD HIGHLIGHTS

  • CBD flower
  • CBD hash
  • Indoor CBD flower
  • Zkittlez CBD
  • Gorilla Glue CBD
  • CBD oil
  • CBD oil 5%
  • CBD oil 10%
  • CBD cream
  • CBD packs
  • CBD wholesale

NEWSLETTER

Want to hear about our offers and get exclusive discounts and gifts? Subscribe here:

SHOPS

Madrid shopC/ Argumosa, 27
28012, Madrid, Spain
Barcelona shopPlaça d'Osca, 6
08014, Barcelona, Spain

CONTACT

  • Contact us
  • (+34) 932 20 48 98
  • info@cannactiva.com
  • Instagram

MEMBERS OF

Cannabishub
Cannabmed
European Industrial Hemp Association
Cluscann

REVIEWS

  • Trustpilot
  • Google – Barcelona shop
  • Google – Madrid shop
  • Cannactiva reviews

CBD products are not medicines and are intended for external use only. Consult a specialist before use if you experience symptoms of pain or illness. Information from Cannactiva and its products is not intended to diagnose, treat or prevent any disease.

Sale restricted to adults aged 18 and over. Products obtained from EU-certified industrial hemp seeds. THC content below 0.3%.

Cannactiva © 2026 All rights reserved

  • Privacy and cookie policy
  • Legal notice
  • Shipping policy: discreet and fast
  • Returns policy
  • Refund policy
  • Terms and conditions
  • Certificates (COA)
  • About us

Cannactiva © 2026 All rights reserved

  1. Home/
  2. CBD blog/
  3. CBD and wellness/
  4. CBD for tics, tremors and other movement disorders
CBD and wellness

CBD for tics, tremors and other movement disorders

Masha Burelo, PhD•November 18, 2024

Last updated: October 30, 2026

CBDCannabis research
CBD for tics, tremors and other movement disorders

Cannabis has been used for medicinal purposes for many years and, in recent decades, cannabidiol (CBD) has stood out for its beneficial properties for various conditions. Although the use of CBD in movement disorders is still being studied, to mark World Movement Disorders Day we want to dedicate this article to explaining what these disorders are, how they manifest themselves, their causes and the potential of cannabis and CBD for treating them.

Note: This is an informative article with no prescriptive character, and it is not intended to prevent, diagnose or treat any disease. Its content can complement, but should never replace, the diagnosis or treatment of any disease or symptom. Cannactiva products are not medicines and are intended for external use. There may be new relevant scientific evidence since the date of publication. Consult your doctor before using CBD. The therapeutic approach must always be personalised and depends on professional assessment.

What are movement disorders?

Movement disorders are involuntary movements resulting from neurological alterations in the central nervous system (1). These movements can affect different parts of the body and vary in their presentation and severity or intensity. Some of the most common movement disorders include dystonia, myoclonus, tremors, tics and stereotypies (2). Each of these disorders has specific characteristics and different underlying causes.

Dystonia

Dystonia manifests itself in the form of involuntary muscle contractions that cause abnormal postures and repetitive movements. This condition can affect a single part of the body, known as focal dystonia; several parts of the body, called segmental dystonia; or the entire body, known as generalised dystonia. Dystonia can have a significant impact on patients' quality of life, making everyday activities such as writing, walking or even speaking difficult (3).

Some causes: Genetic disorders, cerebral palsy, traumatic brain injury, among others.

Myoclonus

Myoclonus consists of brief, rapid, involuntary jerking movements. These movements can be positive or negative; positive myoclonus involves muscle contractions, while negative myoclonus relates to involuntary muscle relaxation. Myoclonus can be focal, affecting a specific area, or generalised, involving multiple areas of the body (4).

Some causes: Neurodegenerative diseases such as Alzheimer's disease, dementia with Lewy bodies, epilepsy, among others.

Tremor

Tremors are rhythmic oscillatory movements that can be classified according to the position in which they occur. Types of tremor include postural tremor (when holding a position), resting tremor (when the body is relaxed), kinetic tremor (during movement) and isometric tremor (during muscle contraction without movement). Tremors can interfere with daily activities such as drinking from a glass or writing (3).

Some causes: They may be of genetic origin, especially in children. In adults, tremors are usually related to alterations in dopamine levels in the brain, as occurs in Parkinson's disease or parkinsonism.

Tics

Tics are sudden, non-rhythmic, rapid movements, which may include vocalisations. These movements can be simple, such as blinking or jerking of the head, or complex, such as gestural movements or repeated phrases. Tics tend to worsen under conditions of exhaustion, anxiety and emotional arousal, and can be a significant source of distress for sufferers (2).

Some causes: Tourette's syndrome, transient or persistent motor disorders, neuropsychiatric conditions.

Stereotypies

Stereotypies are involuntary repetitive and rhythmic movements that serve no apparent purpose and may include complex movements such as body rocking, hand flapping or facial grimacing. Although the exact causes are unknown, these movements are often triggered by factors such as stress, boredom, intense concentration and fatigue (2).

Some causes: Stereotypies may be present in autism spectrum conditions, developmental disorders and other neuropsychiatric contexts.

Diseases that cause movement disorders

Movement disorders can originate from a variety of diseases, such as restless legs syndrome, essential tremor, Tourette's syndrome, Parkinson's disease and Huntington's disease. Each of these conditions has unique characteristics and requires a specific treatment approach.

Traditional treatments for movement disorders, such as medication and surgical interventions, often provide limited relief and can have significant side effects. These side effects can demotivate patients and negatively affect their quality of life.

The pathophysiology of movement disorders is not completely understood. However, it is known that many of these diseases are triggered by imbalances in neurotransmitters, especially in the dopamine, GABA and glutamate systems.

Cannabinoids and movement disorders

THC (tetrahydrocannabinol) and CBD (cannabidiol) are two of the best-known cannabinoids present in the cannabis plant. Both compounds interact with the body's endocannabinoid system, a complex system that regulates various physiological processes, including the modulation of neurotransmission, pain control and inflammation.

Cannabinoids and their role in modulating neurotransmission could help balance brain chemistry, thereby reducing the symptoms of movement disorders. This has been studied in animal models and in some clinical trials, with mixed results.

In 1986, a case study was published that evaluated the effectiveness of CBD for treating dystonia, with promising results (5). This study was instrumental in starting broader research into cannabinoids in the treatment of movement disorders. One of the first studies to evaluate CBD for movement disorders did not report positive results (6). However, years later, it was found that nabilone, a synthetic analogue of THC, could reduce the symptoms of movement disorders, particularly in patients with Huntington's disease (7, 8). These findings suggest that, although CBD may not be effective in all cases, other cannabinoids could offer therapeutic benefits.

Cannactiva CBD oil
Many users consider full spectrum oils to be more effective because of the entourage effect, in which THC enhances the effects of CBD. You can also find CBD oils on the market that contain CBD isolate or broad spectrum CBD, without the effects of THC.

The use of medical cannabis, that is, cannabis with THC, has been shown to significantly reduce tremors and other motor symptoms in patients with Parkinson's disease (9, 10). Although CBD has not shown the same effects in all patients with movement disorders, its ability to improve quality of life through its anxiolytic and antidepressant effects is important (11).

Cannabis plant

Does CBD reduce the psychoactivity of THC?

How CBD works to improve quality of life

Although CBD can help reduce movement disorders in very specific cases, its main benefit lies in improving the emotional state of people living with these problems.

CBD can improve the quality of life of people with movement disorders through its sedative, anxiolytic and antidepressant effects (12-16). These effects are related to the regulation of neurotransmission and the modulation of the dopamine, GABA and glutamate systems. By helping to restore balance in neurotransmitter activity, CBD may relieve some of the symptoms associated with movement disorders.

CBD oil drops for insomnia

CBD for stress

In addition, CBD has beneficial potential for the comorbidities associated with movement disorders because of its anti-inflammatory properties, preserving neuronal function and preventing the progression of the underlying neurodegenerative processes in diseases such as Parkinson's and Huntington's.

CBD oil drops

CBD oil buying guide

CBD dosage for treating movement disorders

The only report that mentioned benefits of CBD in helping with dystonia used a dose of 100 to 600 mg of CBD per day for 6 weeks, alongside the medication prescribed by the doctor. This range is wide and should not be taken as a guideline. Although CBD has an excellent safety profile, it is best to start with low doses and increase them gradually, always under professional supervision.

Drug interactions are an important consideration when you are undergoing medical treatment for movement disorders. It is crucial to bear in mind that CBD can interact with other medicines, and side effects, which can include fatigue, diarrhoea and dizziness, should be carefully monitored.

Conclusion

CBD is a promising therapeutic agent that may improve the quality of life of people with movement disorders. Although other cannabinoids, such as THC, may be more effective in reducing the intensity of symptoms, CBD offers significant benefits in terms of emotional relief and overall wellbeing. Cannabinoids in movement disorders appear to be a very promising area of research, and their use should be carefully supervised by a healthcare professional to maximise benefits and minimise risks.

We hope this article has given you some guidance if you were looking for information about CBD and cannabis in this area of medicine. Please discuss any questions with a professional to get a personalised assessment and advice. This is an informative article with no prescriptive character, and it is not intended to prevent, diagnose or treat any disease. Its content can complement, but should never replace, the diagnosis or treatment of any disease or symptom. Cannactiva products are not medicines and are intended for external use. There may be new relevant scientific evidence since the date of publication. Consult your doctor before using CBD. The therapeutic approach must always be personalised and depends on professional assessment.

References
  1. Harris, M. K., Shneyder, N., Borazanci, A., Korniychuk, E., Kelley, R. E., & Minagar, A. (2009). Movement disorders. The Medical clinics of North America, 93(2), 371–viii. https://doi.org/10.1016/j.mcna.2008.09.002
  2. Wilson, R. B., & Keener, A. M. (2018). Movement Disorders in Children. Advances in pediatrics, 65(1), 229–240. https://doi.org/10.1016/j.yapd.2018.04.010
  3. Sanger, T. D., Chen, D., Fehlings, D. L., Hallett, M., Lang, A. E., Mink, J. W., Singer, H. S., Alter, K., Ben-Pazi, H., Butler, E. E., Chen, R., Collins, A., Dayanidhi, S., Forssberg, H., Fowler, E., Gilbert, D. L., Gorman, S. L., Gormley, M. E., Jr, Jinnah, H. A., Kornblau, B., … Valero-Cuevas, F. (2010). Definition and classification of hyperkinetic movements in childhood. Movement disorders : official journal of the Movement Disorder Society, 25(11), 1538–1549. https://doi.org/10.1002/mds.23088
  4. Burton, Matthew & Dalrymple, W & Figari, Renzo. (2022). Assessment and Treatment of Myoclonus: A Review. Neurology. 18. 38. http://dx.doi.org/10.17925/USN.2022.18.1.38
  5. Consroe, P., Sandyk, R., & Snider, S. R. (1986). Open label evaluation of cannabidiol in dystonic movement disorders. International Journal of Neuroscience, 30(4), 277–282. https://doi.org/10.3109/00207458608985678
  6. Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., & Schram, K. (1991). Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacology, biochemistry, and behavior, 40(3), 701–708. https://doi.org/10.1016/0091-3057(91)90386-g90386-g)
  7. Curtis, A., & Rickards, H. (2006). Nabilone could treat chorea and irritability in Huntington's disease. The Journal of neuropsychiatry and clinical neurosciences, 18(4), 553–554. https://doi.org/10.1176/jnp.2006.18.4.553
  8. Curtis, A., Mitchell, I., Patel, S., Ives, N., & Rickards, H. (2009). A pilot study using nabilone for symptomatic treatment in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 24(15), 2254–2259. https://doi.org/10.1002/mds.22809
  9. Venderová, K., Růzicka, E., Vorísek, V., & Visnovský, P. (2004). Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms. Movement disorders : official journal of the Movement Disorder Society, 19(9), 1102–1106. https://doi.org/10.1002/mds.20111
  10. Lotan, I., Treves, T. A., Roditi, Y., & Djaldetti, R. (2014). Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clinical neuropharmacology, 37(2), 41–44. https://doi.org/10.1097/WNF.0000000000000016
  11. Chagas, M. H., Zuardi, A. W., Tumas, V., Pena-Pereira, M. A., Sobreira, E. T., Bergamaschi, M. M., dos Santos, A. C., Teixeira, A. L., Hallak, J. E., & Crippa, J. A. (2014). Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. Journal of psychopharmacology (Oxford, England), 28(11), 1088–1098. https://doi.org/10.1177/0269881114550355
  12. Chagas, M. H., Crippa, J. A., Zuardi, A. W., Hallak, J. E., Machado-de-Sousa, J. P., Hirotsu, C., Maia, L., Tufik, S., & Andersen, M. L. (2013). Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of psychopharmacology (Oxford, England), 27(3), 312–316. https://doi.org/10.1177/0269881112474524
  13. Crippa, J. A., Zuardi, A. W., Martín-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: a critical review of the evidence. Human psychopharmacology, 24(7), 515–523. https://doi.org/10.1002/hup.1048
  14. Bergamaschi, M. M., Queiroz, R. H., Chagas, M. H., de Oliveira, D. C., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., Martín-Santos, R., Hallak, J. E., Zuardi, A. W., & Crippa, J. A. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 36(6), 1219–1226. https://doi.org/10.1038/npp.2011.6
  15. Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010). Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão? [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 32 Suppl 1, S7–S14.
  16. Zanelati, T. V., Biojone, C., Moreira, F. A., Guimarães, F. S., & Joca, S. R. (2010). Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. British journal of pharmacology, 159(1), 122–128. https://doi.org/10.1111/j.1476-5381.2009.00521.x
CBDCannabis research

More about CBD and wellness

View all
CBD for skin: benefits and how to use it
25 Jun 2026·By Laura Salas

CBD for skin: benefits and how to use it

The benefits of CBD for the skin, how to apply it (topical use) and which CBD skincare to choose, according to scientific studies.

Read more →
Effects of CBD: what it does in your body and how it works
5 Jun 2026·By Andrea Rezes Esmeraldino

Effects of CBD: what it does in your body and how it works

What effects CBD has on the body: what it feels like, how it acts, whether it gets you high, whether it is addictive and how long it lasts. A clear, science-based guide.

Read more →
CBD for muscle recovery: benefits and how to use it
3 Jun 2026·By Masha Burelo, PhD

CBD for muscle recovery: benefits and how to use it

How CBD supports muscle recovery: pain relief, less inflammation and better rest. Ways to use it (creams and oils) and what the science says.

Read more →
CBD for athletes: benefits, sports performance and what the science says
2 Jun 2026·By Masha Burelo, PhD

CBD for athletes: benefits, sports performance and what the science says

Cannabis has many uses for athletes. From CBD physiotherapy creams to CBD oil and hemp protein, you're sure to find what best suits your needs.

Read more →